Warning letter
Lyne Laboratories, Inc.: warning letter of Jan 17, 2008
FDA warning letter UCM1048429 · New England District Office
Key facts
| Reference number | UCM1048429 |
|---|---|
| Company | Lyne Laboratories, Inc. |
| Subject | CGMP for Finished Pharmaceuticals/Adulterated |
| Issue date | Jan 17, 2008 |
| Posted date | Jan 17, 2008 |
| Issuing office | New England District Office |
| Product type | Drugs |
| CFR sections cited | 211.192, 211, 211.160(b) |
| Country | 3 |
| Inspection city | Brockton |
| Inspection ZIP | 02301-5505 |
| Inspection start date | Sep 20, 2007 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: